Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Motives for using Kratom (Mitragyna speciosa Korth.) among regular users in Malaysia
Darshan Singh, Suresh Narayanan, Christian P. Müller, et al.
Journal of Ethnopharmacology (2018) Vol. 233, pp. 34-40
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Kratom—Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review
Steven Eastlack, Elyse M. Cornett, Alan D. Kaye
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 55-69
Open Access | Times Cited: 138
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108879-108879
Open Access | Times Cited: 56
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
Vânia Meireles, Tiago Rosado, Mário Barroso, et al.
Medicines (2019) Vol. 6, Iss. 1, pp. 35-35
Open Access | Times Cited: 60
Kratom use as more than a “self-treatment”
Kirsten E. Smith, Kelly E. Dunn, Jeffrey M. Rogers, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 6, pp. 684-694
Closed Access | Times Cited: 37
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys
Jeffrey M. Rogers, Kayla Colvin, David H. Epstein, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Self-reported prevalence and severity of opioid and kratom (Mitragyna speciosa korth.) side effects
Azlin Saref, Sharifah Suraya, Darshan Singh, et al.
Journal of Ethnopharmacology (2019) Vol. 238, pp. 111876-111876
Closed Access | Times Cited: 51
Kratom Abuse Potential 2021: An Updated Eight Factor Analysis
Jack E. Henningfield, Daniel W. Wang, Marilyn A. Huestis
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 26
Pharmacologic and clinical assessment of kratom: An update
C Michael White
American Journal of Health-System Pharmacy (2019) Vol. 76, Iss. 23, pp. 1915-1925
Closed Access | Times Cited: 40
Kratom instrumentalization for severe pain self-treatment resulting in addiction – A case report of acute and chronic subjective effects
Elisabeth Müller, Thomas Hillemacher, Christian P. Müller
Heliyon (2020) Vol. 6, Iss. 7, pp. e04507-e04507
Open Access | Times Cited: 33
Drug instrumentalization
Christian P. Müller
Behavioural Brain Research (2020) Vol. 390, pp. 112672-112672
Open Access | Times Cited: 33
Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits
Oliver Grundmann, Robert G. Hendrickson, Michael I. Greenberg
Disease-a-Month (2022) Vol. 69, Iss. 6, pp. 101442-101442
Closed Access | Times Cited: 20
A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management
Adina Bowe, Patrick L. Kerr
Journal of Psychoactive Drugs (2020) Vol. 52, Iss. 5, pp. 447-452
Closed Access | Times Cited: 31
Predicted Mode of Binding to and Allosteric Modulation of the μ-Opioid Receptor by Kratom’s Alkaloids with Reported Antinociception In Vivo
Yuchen Zhou, Steven Ramsey, Davide Provasi, et al.
Biochemistry (2020) Vol. 60, Iss. 18, pp. 1420-1429
Open Access | Times Cited: 28
Sex‐Dependent Alcohol Instrumentalization Goals in Non‐Addicted Alcohol Consumers versus Patients with Alcohol Use Disorder: Longitudinal Change and Outcome Prediction
Christian P. Müller, Christiane Mühle, Johannes Kornhuber, et al.
Alcoholism Clinical and Experimental Research (2021) Vol. 45, Iss. 3, pp. 577-586
Open Access | Times Cited: 26
Kratom Alkaloids: Interactions With Enzymes, Receptors, and Cellular Barriers
Nur Aziah Hanapi, Nelson Jeng‐Yeou Chear, Juzaili Azizi, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 24
Diagnostic Ambiguities and Underuse of Clinical Assessment Tools: A Systematic Review of Case Reports on Kratom Addiction and Physical Dependence
Kirsten E. Smith, Jeffrey D. Feldman, Destiny Schriefer, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 282-292
Closed Access | Times Cited: 9
Effects of Nutrient Fertility on Growth and Alkaloidal Content in Mitragyna speciosa (Kratom)
Mengzi Zhang, Abhisheak Sharma, Francisco León, et al.
Frontiers in Plant Science (2020) Vol. 11
Open Access | Times Cited: 25
How Essential is Kratom Availability and use during COVID-19? Use Pattern Analysis Based on Survey and Social Media Data
Oliver Grundmann, Charles A. Veltri, Diana Morcos, et al.
Substance Abuse (2022) Vol. 43, Iss. 1, pp. 865-877
Open Access | Times Cited: 13
Evaluation of toxicity profile of kratom (Mitragyna speciosa Korth) decoction in rats
Zurina Hassan, Darshan Singh, Farah Wahida Suhaimi, et al.
Regulatory Toxicology and Pharmacology (2023) Vol. 143, pp. 105466-105466
Closed Access | Times Cited: 7
DARK Classics in Chemical Neuroscience: Kratom
Changho Han, Joza Schmitt, Kristen Gilliland
ACS Chemical Neuroscience (2019) Vol. 11, Iss. 23, pp. 3870-3880
Closed Access | Times Cited: 22
Self-Report Data on Regular Consumption of Illicit Drugs and HIV Risk Behaviors after Kratom (Mitragyna Speciosa korth.) Initiation among Illicit Drug Users in Malaysia
Azlin Saref, Sharifah Suraya, Darshan Singh, et al.
Journal of Psychoactive Drugs (2019) Vol. 52, Iss. 2, pp. 138-144
Closed Access | Times Cited: 21
Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study
Antonio Metastasio, Elisabeth Prevete, Darshan Singh, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top